发明名称 Crystalline [r-(r*,r*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl
摘要 The specification describes crystalline [R-(R*,R*)]-2-(4-fluorophenyl)- beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4 [(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemi calcium salt designated Form I. The compound also known as atorvastatin is characterized by its X-ray powder diffraction and/or solid state NMR. Also described are methods for the preparation and pharmaceutical composition of the same. The compounds are useful as agents for treating hyperlipidemia and hypercholesterolemia.
申请公布号 NZ312907(A) 申请公布日期 2000.12.22
申请号 NZ19960312907 申请日期 1996.07.08
申请人 WARNER-LAMBERT COMPANY 发明人 BRIGGS, CHRISTOPHER A;JENNINGS, REX ALLEN;WADE, ROBERT A;HARASAWA, KIKUKO;ICHIKAWA, SHIGERU;MINOHARA, KAZUO;NAKAGAWA, SHINSUKE
分类号 C07D207/34;A61K31/40;A61P3/06;A61P3/14;A61P43/00;C07D;(IPC1-7):A61K31/40 主分类号 C07D207/34
代理机构 代理人
主权项
地址